The University of Chicago Header Logo

Connection

Mohammad Atiq to Drug Resistance, Neoplasm

Back to Details
This is a "connection" page, showing publications Mohammad Atiq has written about Drug Resistance, Neoplasm.
Mohammad Atiq
Connection Strength
0.134
Drug Resistance, Neoplasm
  1. Ribonucleotide reductase small subunit M2 is a master driver of aggressive prostate cancer. Mol Oncol. 2020 08; 14(8):1881-1897.
    View in: PubMed
    Score: 0.134
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.